Immunological predictors of HIV-related survival

International Journal of STD and AIDS

Volumn 10, Issue 7, 1999, Pages 467-470

  Baillargeon, Jacques ^a   Grady, James ^b   Borucki, Michael J ^c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

CD8 lymphocyte count; Epidemiology; Survival; Survival analysis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CD4-CD8 RATIO; COHORT STUDIES; CONFIDENCE INTERVALS; HIV INFECTIONS; HUMANS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0032998070     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991914483     Document Type: Article

References (19)

1. 1 Saah AJ, Hoover DR, He Y, et al. Factors influencing survival after AIDS: report from the mullicenter AIDS cohort study. J Acquir Immune Defic Syndr 1994;7:287-95
2. 2 Stein U, Korvick J, Vermud S. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992;165:352-63
3. 3 Taylor J, Fahey JL, Detels R, Giorgi J. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 1989;2:114-24
4. 4 Lang W, Perkins H, Anderson RE, Royce R, Winkelstein W. Patterns of T-lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989;2:63-9
5. 5 Anderson R, Shiboski S, Royce R, Jewell N, Lang W, Winkelstein W. CD8 T lymphocyte and progression to AIDS in HIV-infected men: some observations. AIDS 1991;5:213-15
6. 6 Chevret C, Roquin H, Ganne P, Lefrere J. Prognostic value of an elevated CD8 lymphocyte count in HIV infection: results of a prospective study of 152 asymptomatic HIV-positive individuals. AIDS 1992;6:1349-51
7. 7 Fahey J, Taylor J, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-72
8. 8 Fernandez-Cruz E., Desco M, Montes M, Longo N, Gonzalez B, Zabay JM. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users. AIDS 1990;4:987-8
9. 9 Koszinowski UH, Del Val M, Reddehase MJ. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr Top Microbiol Immunol 1990;154:189-219
10. 10 Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-6
11. 11 Walker CM, Moody DJ, Sittes DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-6
12. 12 Fiala M, Swartz J, Teklehaimanot S, et al. Zidovudine therapy, CD4+ and CD8+ counts arc associated with a longer survival following AIDS onset. Lymphology 1997;30:128-36
13. 13 Kamps BS, Brodt R, Staszewski S, Bergmann L, Helm E. AIDS-free survival and overall survival in HIV infection: the new classification system for HIV disease and AIDS. Clin Invest 1994;72:283-7
14. 14 Chaisson RE, Keruly J, Richman DD, Moore RD. Pneumocystis prophylaxis and survival in patients with AIDS and advanced AIDS related complex. JAMA 1989;262:2405-10
15. 15 Moore RD, Keruly J, Richman DD, et al. Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 1992;6:671-7
16. 16 Allison P. Survival Analysis Using the SAS System: A Practical Guide. Cary, North Carolina: SAS Institute, Inc., 1995
17. 17 Kleinbaum D. Survival Analysis: A Self-Learning Text. New York: Springer, 1995
18. 18 Stein DS, Korvick JA, Vermud SH. CD4 lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992;165:352-63
19. 19 Vittinghoff F, Malain HM, Jewell NP. Estimating patterns of CD4 lymphocyte decline using data from a prevalent cohort of HIV infected individuals. Stat Med 1994;13:1101-18